Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 2013. The report details a specific share repurchase transaction executed on March 13, 2013, in accordance with shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 330,000 Ordinary Shares of 25 pence each.
- Price Range: Highest price paid was 1,494 pence per share; lowest price paid was 1,482 pence per share.
- Treasury Holdings (Settled): 495,691,327 shares, representing 9.17% of total issued share capital.
- Treasury Holdings (Including Unsettled): 496,761,327 shares, representing 10.12% of current total voting rights.
- Shares in Issue (Excluding Treasury): 4,907,778,303 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 330,000 shares for Treasury. Consequently, the percentage of total voting rights held in Treasury increased to 10.12% when including unsettled purchases. The filing does not provide comparative data against prior periods for these specific metrics.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. It is a routine disclosure of a share repurchase activity compliant with the Financial Services Authority's Disclosure and Transparency Rules.
Investor Verification Points
- Verify the total cost of the 330,000 shares purchased based on the reported price range (1,482 to 1,494 pence).
- Confirm the impact of the 10.12% Treasury holding on the denominator used for calculating shareholder notification thresholds under Disclosure and Transparency Rules.
- Check subsequent filings for the settlement status of the shares purchased but not yet settled at the time of this report.